awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26796436-AE7580DD-83EB-4FAD-AC65-99E3FC098C22
Q26796436-AE7580DD-83EB-4FAD-AC65-99E3FC098C22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796436-AE7580DD-83EB-4FAD-AC65-99E3FC098C22
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature
P2860
Q26796436-AE7580DD-83EB-4FAD-AC65-99E3FC098C22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796436-AE7580DD-83EB-4FAD-AC65-99E3FC098C22
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c653d8eb2923f697aaab4550445e29ba78ce6613
P2860
A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.